TARA

Protara Therapeutics, Inc. Common Stock

7.01

USD

TARA Earnings Reports

Positive Surprise Ratio

TARA beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report

Mar 03, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.33

Implied change from Q3 25 (Revenue/ EPS)

+6.45%

Implied change from Q4 24 (Revenue/ EPS)

-32.65%

Protara Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, TARA reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -0.39 USD, resulting in a 20.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.59% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an increase of 6.45% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Protara Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Protara Therapeutics, Inc. Common Stock reported EPS of -$0.31, beating estimates by 20.86%, and revenue of $0.00, 0% as expectations.

How did the market react to Protara Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 5.59%, changed from $4.29 before the earnings release to $4.53 the day after.

When is Protara Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 03, 2026.

What are the forecasts for Protara Therapeutics, Inc. Common Stock's next earnings report?

Based on 7 analysts, Protara Therapeutics, Inc. Common Stock is expected to report EPS of -$0.33 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.